Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | |
|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||
| Cash from operating activities | 72.38%24.76B | 9.35%14.36B | -5.44%13.14B | 13.89B |
| Net profit before non-cash adjustment | 219.58%19.19B | -23.83%6.01B | 2.91%7.89B | --7.66B |
| Total adjustment of non-cash items | 21.86%11.43B | 56.03%9.38B | 8.76%6.01B | --5.53B |
| -Depreciation and amortization | 32.90%8.59B | 2.47%6.47B | 14.89%6.31B | --5.49B |
| -Reversal of impairment losses recognized in profit and loss | 17,316.67%3.14B | -35.71%18M | --28M | --0 |
| -Assets reserve and write-off | ---- | --2.03B | --0 | ---- |
| -Share of associates | 33.52%-119M | 22.51%-179M | -57.14%-231M | ---147M |
| -Disposal profit | 75.38%-32M | -22.64%-130M | 0.00%-106M | ---106M |
| -Other non-cash items | -112.56%-148M | 11,680.00%1.18B | -96.53%10M | --288M |
| Changes in working capital | -475.10%-5.87B | -34.74%-1.02B | -207.83%-757M | --702M |
| -Change in receivables | -544.36%-7.89B | -1,510.53%-1.22B | 79.40%-76M | ---369M |
| -Change in inventory | -431.58%-315M | 137.40%95M | -193.04%-254M | --273M |
| -Change in payables | 6,038.46%2.32B | 84.46%-39M | -150.91%-251M | --493M |
| -Provision for loans, leases and other losses | -86.49%20M | 184.09%148M | -157.70%-176M | --305M |
| Dividends paid (cash flow from operating activities) | ||||
| Dividends received (cash flow from operating activities) | -42.19%74M | 43.82%128M | 89M | 0 |
| Interest paid (cash flow from operating activities) | -55.19%-523M | -11.59%-337M | -18.90%-302M | -254M |
| Interest received (cash flow from operating activities) | 112.50%17M | -33.33%8M | -67.57%12M | 37M |
| Tax refund paid | -13.66%-2.32B | 46.61%-2.04B | -43.96%-3.83B | -2.66B |
| Other operating cash inflow (outflow) | -3,075.34%-2.17B | -1.35%73M | 74M | 0 |
| Operating cash flow | 62.66%19.84B | 32.77%12.19B | -16.64%9.18B | --11.02B |
| Investing cash flow | ||||
| Net business purchase and sale | ---- | 93.56%-91M | ---1.41B | --0 |
| Net investment product transactions | 100.08%4M | -166,866.67%-5B | -99.12%3M | --342M |
| Net changes in other investments | -3.08%-12.09B | -121.90%-11.73B | -112.12%-5.28B | ---2.49B |
| Investing cash flow | 28.16%-12.08B | -151.29%-16.82B | -211.45%-6.69B | ---2.15B |
| Financing cash flow | ||||
| Net issuance payments of debt | 96.94%8.05B | 2,518.34%4.09B | 93.67%-169M | ---2.67B |
| Net common stock issuance | -219,900.00%-4.4B | 75.00%-2M | 46.67%-8M | ---15M |
| Increase or decrease of lease financing | 16.74%-194M | 11.07%-233M | -100.00%-262M | ---131M |
| Cash dividends paid | 0.77%-2.07B | 10.23%-2.09B | -177.23%-2.33B | ---839M |
| Cash dividends for minorities | -30.56%-47M | 21.74%-36M | -64.29%-46M | ---28M |
| Net other fund-raising expenses | 242.86%170M | -643.75%-119M | 11.11%-16M | ---18M |
| Financing cash flow | -6.40%1.51B | 156.92%1.61B | 23.59%-2.83B | ---3.7B |
| Net cash flow | ||||
| Beginning cash position | -12.73%20.66B | -1.40%23.68B | 133.55%24.01B | --10.28B |
| Current changes in cash | 407.00%9.26B | -797.62%-3.02B | -106.50%-336M | --5.17B |
| Cash adjustments other than cash changes | ---- | --1M | ---- | --8.56B |
| End cash Position | 44.81%29.92B | -12.73%20.66B | -1.40%23.68B | --24.01B |
| Free cash flow | 62.66%19.84B | 32.77%12.19B | -16.64%9.18B | --11.02B |
| Currency Unit | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |